- Report
- June 2024
- 200 Pages
Global
From €7535EUR$7,950USD£6,295GBP
- Report
- January 2022
- 60 Pages
Global
From €3744EUR$3,950USD£3,128GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1422EUR$1,500USD£1,188GBP
Hypovolemia is a condition in which the body has an abnormally low volume of blood. It is a common complication of cardiovascular diseases, and is often treated with drugs. Cardiovascular drugs used to treat hypovolemia include diuretics, vasopressors, and inotropes. Diuretics are used to reduce fluid retention, while vasopressors and inotropes are used to increase blood pressure and cardiac output. Other drugs used to treat hypovolemia include anticoagulants, antiarrhythmics, and antithrombotics.
The hypovolemia drug market is a rapidly growing segment of the cardiovascular drug market. It is driven by the increasing prevalence of cardiovascular diseases, as well as the development of new drugs to treat hypovolemia. Companies in the hypovolemia drug market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. Show Less Read more